A population of CD38+ cells expressing IgA, IL‐10, and PD‐L1 have been identified in prostate cancer49 and hepatocellular carcinomas,50 and have been shown to suppress CD8+ T cells activation and exhibit immunosuppressive effects. This evidence concerns the gene CD38 and hepatocellular carcinoma.